Clinical Trial: Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients with Obesity Complicated by Chronic Kidney Disease with Albuminuria (China)

China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients with Obesity Complicated by Chronic Kidney Disease with Albuminuria'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132135

Registration Time: 2026/09/09

Type: Interventional study

Primary Sponsor: Peking University People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338857

Published by HT Digital Content Services with permission from Health Daily Digest....